Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proximod in Moderate-to-Severe Active Rheumatoid Arthritis
NCT07856511Phase 3Not yet recruiting
- Sponsor
- Jian Kuan Biotechnology
- Start
- Oct 2026
- Primary completion
- Apr 2027
01
Overview
A Phase 3 trial of proximod in rheumatoid arthritis (RA), sponsored by Jian Kuan Biotechnology. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
proximod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07856511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07856511.